Transaction · 0001396867-26-000004

Lakkaraju Roop Kalyan

Lakkaraju Roop Kalyan, EVP, CFO, reported a transaction classified as exercise at BIO-RAD LABORATORIES, INC. involving 1536.000000 shares for an estimated $0.00. Reported holdings after the transaction were 3072.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CFO
BIO BIO.BBIO-RAD LABORATORIES, INC.
Trade date
Sep 06, 2026
Filing date
Sep 09, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded1.53k$0.00 per share
Holdings after3.07kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

BIO BIO.B price since this filing

Daily closing prices, with the filing date and available return windows
BIO BIO.B · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001396867-26-000004
Restricted Stock Units
Transaction date
Sep 06, 2026
Filed Sep 09, 2026, 10:42 PM · 3d delay
Shares
1,536 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
3,072 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares of Class A common stock acquired on the vesting of restricted stock units.

  2. F2

    Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026.

  3. F3

    Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

  4. F4

    The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.

  5. F5

    The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

Original filing · 0001396867-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BIO BIO.B